SCHEMBL1343463

SCHEMBL1343463

COc1ccccc1C(=O)c1cc(C)ccc1NC(=O)Nc1ncc(C(C)N=C(N)N)s1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.46
GAA P10253 1/20 0.46
LPAR1 Q92633 2/20 0.41
KCNMA1 Q12791 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 2/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 5/20 0.39
MEN1 O00255 4/20 0.39
ALDH1A1 P00352 1/20 0.39
PKM P14618 1/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1343063 0.83 TP53 (0.52) TP53GAALPAR1KCNMA1NPC1
SCHEMBL1342881 0.81 TP53 (0.53) TP53GAAKCNMA1NPC1RAB9A
SCHEMBL1342697 0.81 TP53 (0.53) TP53GAALPAR1KCNMA1NPC1
SCHEMBL6701130 0.81 TP53 (0.49) TP53GAAKCNMA1NPC1RAB9A
SCHEMBL1343141 0.80 GAA (0.55) TP53GAALPAR1KCNMA1NPC1
SCHEMBL6695210 0.80 CCNE1 (0.39) LPAR1CCNE1CDK2CDK5SMN1; SMN2
SCHEMBL2650328 0.80 GAA (0.46) TP53GAAKCNMA1NPC1RAB9A
SCHEMBL1497603 0.79 GAA (0.48) TP53GAAKCNMA1NPC1RAB9A
SCHEMBL1342128 0.79 TP53 (0.42) TP53GAALPAR1KCNMA1CCNE1
SCHEMBL6697170 0.79 TP53 (0.42) TP53GAALPAR1KCNMA1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063081-B2 N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-11-22 US disclosed
US-7897628-B2 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-03-01 US disclosed